13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q4 2024 · Filed February 6, 2025 · Accession 0001104659-25-010152
Total Value
$819.7M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | KYMR | 4,896,462 | $197.0M | 24.03% |
| 2 | Dyne Therapeutics, Inc. | DYN | 8,019,354 | $188.9M | 23.05% |
| 3 | Disc Medicine, Inc. | IRON | 2,509,456 | $159.1M | 19.41% |
| 4 | Third Harmonic Bio, Inc. | 88427A107 | 10,402,286 | $107.0M | 13.06% |
| 5 | Day One Biopharmaceuticals, Inc. | DAWN | 6,430,257 | $81.5M | 9.94% |
| 6 | Korro Bio, Inc. | KRRO | 1,137,149 | $43.3M | 5.28% |
| 7 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $9.9M | 1.21% |
| 8 | Generation Bio, Co. | 37148K100 | 8,279,484 | $8.8M | 1.07% |
| 9 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $8.2M | 1.00% |
| 10 | Q32 Bio, Inc. | QTTB | 2,092,106 | $7.2M | 0.88% |
| 11 | Aerovate Therapeutics, Inc. | 008064107 | 1,799,232 | $4.8M | 0.58% |
| 12 | Tectonic Therapeutics, Inc. | TECX | 78,447 | $3.6M | 0.44% |
| 13 | Spero Therapeutics, Inc. | SPRO | 305,255 | $314,413 | 0.04% |